A comparison of the anti‐arrhythmic actions of I.C.I. 50172 and (—)‐propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function
- 1 October 1969
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 37 (2) , 391-399
- https://doi.org/10.1111/j.1476-5381.1969.tb10576.x
Abstract
1. I.C.I. 50172 had marked quinidine-like effects on intracellular cardiac action potentials at concentrations above 20 mg/l. (6.61 x 10(-5)M). The rate of rise and overshoot of the action potential, conduction velocity and contractions were decreased. (-)-Propranolol had similar effects at less than 1/30 this concentration.2. I.C.I. 50172 had 1/100 the activity of (-)-propranolol as a local anaesthetic. Since this is also the ratio of their in vitro beta-receptor blocking activities, I.C.I. 50172 provides no net increase in specificity of beta-receptor blockade.3. In contrast, the in vivo activity of I.C.I. 50172 in protecting anaesthetized guinea-pigs against ouabain-induced ventricular fibrillation was 40% that of (-)-propranolol.4. Structure-activity relations of beta-receptor blocking drugs are discussed.Keywords
This publication has 43 references indexed in Scilit:
- Adrenaline: Mechanism of Action on the Pacemaker Potential in Cardiac Purkinje FibersScience, 1968
- Clinical Use of I.C.I. 50172 as an Antidysrhythmic Agent in Heart FailureBMJ, 1968
- Cardio-selective ?-blockadeNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1968
- The cardiac beta-adrenergic receptor blocking actions of propranolol and its stereoisomersLife Sciences, 1967
- EVALUATION OF THE CARDIAC EFFECTS OF SEVERAL BETA ADRENERGIC BLOCKING AGENTSAnnals of the New York Academy of Sciences, 1967
- Optical Isomers of PropranololNature, 1966
- A NEW ADRENERGIC: BETA-RECEPTOR ANTAGONISTPublished by Elsevier ,1964
- Local Anæsthetic Activity of the β-Receptor Antagonist, PronethalolNature, 1964
- PREVENTION OF ARRHYTHMIAS DUE TO CARDIAC GLYCOSIDES BY BLOCK OF SYMPATHETIC β RECEPTORSThe Lancet, 1963
- PHARMACOLOGY OF A NEW ADRENERGIC BETA-RECEPTOR-BLOCKING COMPOUND (NETHALIDE)The Lancet, 1962